MRT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Marti Technologies is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock is trading around 2.07 in pre-market, but the technical setup is weak, there is no strong proprietary buy signal, and the latest analyst updates show mixed-to-cautious sentiment with price target cuts. Based on the current data, I would not buy it now; holding off is the better choice.
The trend is weak and still bearish. MACD histogram is below zero, although it is slightly contracting, which suggests downside momentum is easing but not yet reversing. RSI_6 is near 50, indicating no clear directional edge. The moving average structure is bearish with SMA_200 > SMA_20 > SMA_5, which confirms the broader trend is still down. Price is sitting very close to pivot support at 2.067, with immediate support at 2.028 and 2.005. Resistance is near 2.105 and 2.128. The short-term setup does not show a clean bullish breakout, and the pattern-based forecast is only modest for the next day with weaker expectations over the next week and month.
Roth Capital said Marti delivered a strong beat versus original 2025 guidance, raised its first-half outlook for riders and drivers, and maintained full-year 2026 revenue and EBITDA targets. The company is also diversifying beyond ride-hailing in Istanbul, with growing monetization in newer cities and early traction in delivery services. These are constructive operating catalysts.
Cantor Fitzgerald lowered its price target to $2.15 from $3 and kept a Neutral rating, reflecting caution about the company still being early in its ride-hailing transition. Roth Capital also cut its target to $4 from $5, citing a higher share count. There has been no news in the past week, hedge funds and insiders are neutral, and there is no recent congress trading data. The broader market tone is also weak in pre-market with the S&P 500 down 0.82%.
Latest quarter financials were not provided due to an error in the financial snapshot, so a full quarter-by-quarter assessment is not available. The available guidance-related commentary suggests the company recently beat its original 2025 guidance and raised first-half outlooks, while still maintaining its full-year 2026 revenue and EBITDA targets. That points to improving operating momentum, but the lack of detailed quarterly figures limits confidence.
Recent analyst sentiment is mixed. Roth Capital remained bullish with a Buy rating but reduced its price target from $5 to $4, mainly due to a higher share count, while noting strong operational progress. Cantor Fitzgerald cut its target from $3 to $2.15 and stayed Neutral, emphasizing that the company is still early in its transition. Overall, Wall Street appears divided: the pros see business progress and diversification, but the valuation and execution story are still not strong enough for a clear broad-buy consensus.
